PIK3R3 inhibits cell senescence through p53/p21 signaling

被引:41
|
作者
Chen, Qianzhi [1 ,2 ]
Sun, Xuling [1 ]
Luo, Xuelai [1 ]
Wang, Jing [3 ]
Hu, Junbo [1 ]
Feng, Yongdong [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept GI,Canc Res Inst, Wuhan, Hubei, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Breast & Thyroid Surg, Wuhan, Hubei, Peoples R China
[3] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Immunol, Basic Med, Wuhan, Hubei, Peoples R China
基金
中国国家自然科学基金;
关键词
TUMOR-SUPPRESSOR; UP-REGULATION; CANCER; P21; RB;
D O I
10.1038/s41419-020-02921-z
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cellular senescence is a stress response of human cells that removes potentially harmful cells by initiating cell cycle arrest. Inducing senescence of tumor cells may be an effective tumor-inhibiting strategy. In this study we found that PIK3R3 could inhibit the cell senescence of colorectal cancer cells and promote cell proliferation through the p53/p21 signal pathway. PIK3R3 could bind to p53 and inhibit the binding of p53 to the p21 gene promoter region, and thus affecting the transcriptional activity of p21 gene. Our study has provided new evidence of the role of PIK3R3 in p53 regulation and inhibition of PIK3R3 may be one of the potential targets of tumor therapy.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] PIK3R3 inhibits cell senescence through p53/p21 signaling
    Qianzhi Chen
    Xuling Sun
    Xuelai Luo
    Jing Wang
    Junbo Hu
    Yongdong Feng
    Cell Death & Disease, 11
  • [2] MicroRNA-29c-3p inhibits osteosarcoma cell proliferation through targeting PIK3R3
    Ma, H-Z
    Wang, J.
    Shi, J.
    Zhang, W.
    Zhou, D-S
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (05) : 2239 - 2247
  • [3] Triiodothyronine acts on DAO to regulate pulmonary fibrosis progression by facilitating cell senescence through the p53/p21 signaling pathway
    Guo, Xiaoshu
    Xu, Kai
    Wang, Lan
    Ding, Linke
    Li, Wenwen
    Zhang, Xinsheng
    Zhao, Weiming
    Wang, Ningdan
    Wang, Gaiping
    Zhao, Wenyu
    Rosas, Ivan
    Yu, Guoying
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [4] MLN8237 Induces Cellular Senescence of Neuroblastoma Cells Through the P53/P21 Signaling Pathway
    Liu, A.
    Ding, L.
    Hu, Q.
    Yang, Y.
    Sun, J.
    Zhang, A.
    Wang, Y.
    Nie, D.
    Hu, Y.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S245 - S246
  • [5] Decline of p300 contributes to cell senescence and growth inhibition of hUC-MSCs through p53/p21 signaling pathway
    Li, Yasha
    Zhong, Haiying
    Wu, Mengyun
    Tan, Bin
    Zhao, Li
    Yi, Qin
    Xu, Xiaohui
    Pan, Huafeng
    Bi, Yang
    Yang, Ke
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 515 (01) : 24 - 30
  • [6] Agmatine Ameliorates High Glucose-Induced Neuronal Cell Senescence by Regulating the p21 and p53 Signaling
    Song, Juhyun
    Lee, Byeori
    Kang, Somang
    Oh, Yumi
    Kim, Eosu
    Kim, Chul-Hoon
    Song, Ho-Taek
    Lee, Jong Eun
    EXPERIMENTAL NEUROBIOLOGY, 2016, 25 (01) : 24 - 32
  • [7] Glutaredoxin-1 Silencing Induces Cell Senescence via p53/p21/p16 Signaling Axis
    Yang, Fan
    Yi, Meiqi
    Liu, Yan
    Wang, Qjngtao
    Hu, Yadong
    Deng, Haiteng
    JOURNAL OF PROTEOME RESEARCH, 2018, 17 (03) : 1091 - 1100
  • [8] Possible involvement of p21 but not of p16 or p53 in keratinocyte senescence
    Sayama, K
    Shirakata, Y
    Midorikawa, K
    Hanakawa, Y
    Hashimoto, K
    JOURNAL OF CELLULAR PHYSIOLOGY, 1999, 179 (01) : 40 - 44
  • [9] circLARP4 induces cellular senescence through regulating miR-761/RUNX3/p53/p21 signaling in hepatocellular carcinoma
    Chen, Zhiqiang
    Zuo, Xueliang
    Pu, Liyong
    Zhang, Yao
    Han, Guoyong
    Zhang, Long
    Wu, Jindao
    Wang, Xuehao
    CANCER SCIENCE, 2019, 110 (02) : 568 - 581
  • [10] Hyperacetylation of the C-terminal domain of p53 inhibits the formation of the p53/p21 complex
    Kim, Ukjin
    Kim, Kwang Seok
    Park, Jong-Kuk
    Um, Hong -Duck
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 635 : 52 - 56